Aspira Women's Health Inc. (AWH) Q4 2021 Results Conference Call March 23, 2022 8:30 AM ET
Company Participants
Valerie Palmieri - Executive Chair of the Board
Nicole Sanford - President and Chief Executive Officer
Rob Beechey - Chief Financial Officer
Conference Call Participants
Ross Osborn - Cantor Fitzgerald
Kumar Raja - Brookline
Operator
Good morning, ladies and gentlemen, and welcome to Aspira Women's Health Inc.'s Full Year 2021 and Fourth Quarter 2021 Conference Call. My name is Kyle, and I will be your coordinator for the call today. [Operator Instructions]
As a reminder, this conference call is being recorded today. Leading the call today are Valerie Palmieri, Executive Chair of the Board; Nicole Sanford, President and Chief Executive Officer; and Bob Beechey, Chief Financial Officer. After the prepared remarks, we will open the call for Q&A.
Before we begin, I would like to remind everyone that forward-looking statements defined under the Private Securities Litigation Reform Act of 1995, will be made during this call, including statements relating to Aspira's expected future performance, future business prospects or future events or plans. Although the company believes that the expectations reflected in such forward-looking statements are based upon reasonable assumptions, actual outcomes and results are subject to risks and uncertainties and could differ materially from those anticipated due to the impact of many factors beyond the control of Aspira.
The company assumes no obligation to update or supplement any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. Participants are directed to the cautionary note set forth in today's press release as well as the risk factors set forth in Aspira's most recent Form 10-K and our second quarter 2021 Form 10-Q filed with the SEC for a description of factors that could cause actual results to differ
- Read more current AWHL analysis and news
- View all earnings call transcripts